APOBR Is Downregulated in EBV+ Tonsils of Children with Obstructive Sleep-Disordered Breathing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel : MDPI
    • Subject Terms:
    • Abstract:
      Background: Obstructive sleep-disordered breathing (oSDB) is a heterogeneous phenotype that is increasing in prevalence worldwide and has many potential comorbidities that could severely affect quality of life. There is a need to identify biomarkers for oSDB and its comorbidities to improve clinical management, particularly in children. Methods: We performed bulk mRNA-sequencing, differential expression analysis, and qPCR replication of selected differentially expressed genes (DEGs) using RNA samples extracted from tonsils of children with oSDB. Two variables were used as classifier, namely, detection of Epstein-Barr virus (EBV) in tonsils and need for continuous positive airway pressure (CPAP) treatment. Standard statistical tests were used to determine associations across clinical, EBV, and DEG variables. Results: Nineteen genes were dysregulated in tonsils that are EBV+ or from children needing CPAP. Of these genes, APOBR was downregulated in both EBV+ and CPAP+ tonsils, and this downregulation was replicated by qPCR in an independent set of pediatric samples. In the tonsils of adult patients with oSDB, APOBR was positively correlated with age, and potentially with diastolic blood pressure. Conclusion s: Taken together, APOBR and DEGs in tonsillar tissues may be useful as potential biomarkers of oSDB severity and comorbidity across the lifespan, with APOBR levels being dependent on latent EBV infection.
    • References:
      Int J Pediatr Otorhinolaryngol. 2014 Mar;78(3):561-2. (PMID: 24480119)
      Int Forum Allergy Rhinol. 2023 Jul;13(7):1061-1482. (PMID: 36068685)
      Genome Biol. 2014;15(12):550. (PMID: 25516281)
      Database (Oxford). 2015 Sep 30;2015:. (PMID: 26424082)
      J Rheumatol. 1988 Mar;15(3):479-82. (PMID: 2837573)
      Am J Respir Crit Care Med. 2018 May 1;197(9):1187-1197. (PMID: 29327943)
      Int J Pediatr Otorhinolaryngol. 2016 Nov;90:128-132. (PMID: 27729119)
      Nucleic Acids Res. 2014 Jul;42(Web Server issue):W167-74. (PMID: 24861621)
      Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110276. (PMID: 32810686)
      Otolaryngol Head Neck Surg. 2019 Feb;160(2):187-205. (PMID: 30921525)
      Am J Respir Crit Care Med. 2010 May 15;181(10):1114-20. (PMID: 20093640)
      JAMA. 2023 Dec 5;330(21):2084-2095. (PMID: 38051326)
      J Fam Pract. 1991 Jul;33(1):33-7. (PMID: 2056288)
      Laryngoscope. 2021 Nov;131(11):2616-2624. (PMID: 34626128)
      J Clin Sleep Med. 2019 Feb 04;15(2):335-343. (PMID: 30736887)
      J Clin Sleep Med. 2020 Apr 15;16(4):631-633. (PMID: 32003733)
      PLoS One. 2017 Oct 26;12(10):e0185056. (PMID: 29073143)
      Sleep Med. 2000 Feb 1;1(1):21-32. (PMID: 10733617)
      Arch Intern Med. 1986 Jul;146(7):1333-5. (PMID: 3718130)
      Genome Med. 2015 Oct 08;7:103. (PMID: 26449484)
      Twin Res Hum Genet. 2021 Jun;24(3):145-154. (PMID: 34340725)
      Genes (Basel). 2018 May 03;9(5):. (PMID: 29751582)
      Laryngoscope. 2019 Mar;129(3):761-770. (PMID: 30588639)
      Laryngoscope. 2021 Jul;131(7):1676-1682. (PMID: 33443811)
      Sleep Breath. 2023 Dec;27(6):2407-2413. (PMID: 37389766)
      Nat Genet. 2022 Aug;54(8):1125-1132. (PMID: 35835914)
      J Med Virol. 2019 Apr;91(4):687-697. (PMID: 30318627)
      Otolaryngol Head Neck Surg. 2019 Feb;160(1_suppl):S1-S42. (PMID: 30798778)
      Blood. 1995 Feb 1;85(3):744-50. (PMID: 7530505)
      Clin Chest Med. 2023 Sep;44(3):585-603. (PMID: 37517837)
      EBioMedicine. 2023 Apr;90:104536. (PMID: 36989840)
      J Clin Sleep Med. 2022 Jun 1;18(6):1573-1581. (PMID: 35164899)
      J Med Virol. 2017 Jun;89(6):1088-1095. (PMID: 27864888)
      Laryngoscope. 2024 Feb;134(2):981-986. (PMID: 37672634)
      Arch Pediatr Adolesc Med. 2010 Sep;164(9):803-9. (PMID: 20819961)
      J Virol. 2022 Jan 12;96(1):e0143421. (PMID: 34643432)
      Ther Clin Risk Manag. 2023 Feb 03;19:143-162. (PMID: 36761690)
      J Infect Dev Ctries. 2019 Aug 31;13(8):764-767. (PMID: 32069263)
      Nat Methods. 2017 Apr;14(4):417-419. (PMID: 28263959)
      J Med Virol. 2022 Sep;94(9):4470-4477. (PMID: 35488185)
      Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7488-93. (PMID: 10852956)
      Ann Am Thorac Soc. 2021 Apr;18(4):656-667. (PMID: 33064953)
      J Allergy Clin Immunol. 2019 Feb;143(2):691-699. (PMID: 29679657)
      Allergy. 2023 Feb;78(2):522-536. (PMID: 35899482)
    • Grant Information:
      T32 DC012280 United States DC NIDCD NIH HHS; R25 HG012994 United States HG NHGRI NIH HHS
    • Contributed Indexing:
      Keywords: APOBR; CPAP; EBV; Epstein–Barr virus; RNA-seq; bulk mRNA sequencing; continuous positive airway pressure; obstructive sleep-disordered breathing; sleep apnea; tonsil
    • Accession Number:
      0 (Biomarkers)
    • Publication Date:
      Date Created: 20241026 Date Completed: 20241026 Latest Revision: 20241104
    • Publication Date:
      20241104
    • Accession Number:
      PMC11507010
    • Accession Number:
      10.3390/genes15101324
    • Accession Number:
      39457448